ArticleOncoimmunology2021

Safety, Tolerability, and Long-Term Clinical Outcomes of an IL-15 analogue (N-803) Admixed with Bacillus Calmette-Guérin (BCG) for the Treatment of Bladder Cancer.

Charles J Rosser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.